long intergenic non-protein coding RNA 1515Genealiases: []
Q-omics provides the consensus-scored LINC01515 profile across patient tissues and cancer cell-line models. LINC01515 expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in UCS. Among the 18 cancer types available for tumor–normal comparison, LINC01515 is differentially expressed in 12, with the highest sampling consensus in KIRP. Additionally, LINC01515 RNA expression shows 17,441 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight UCS, KIRP, and UVM as cancer lineages where LINC01515 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01515 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01515 survival associations across molecular data types. LINC01515 RNA expression shows survival associations in the most cancer types (25). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01515 RNA expression–survival associations across cancer types. High LINC01515 expression shows unfavorable associations in LGG and THCA, but favorable associations in UCS, SKCM, HNSC and MESO. The UCS Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCS as the clearest survival context for LINC01515 RNA expression.
This table summarizes LINC01515 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in KIRP for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01515. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01515 shows lower tumor expression in KICH and higher tumor expression in KIRP, LUAD, KIRC, LIHC and CHOL. The KIRP box plot shows higher LINC01515 RNA expression in tumor versus normal tissue (log2 FC = +0.421, t-test p = .001).
This table shows molecular features associated with LINC01515 in patient tissues and cancer cell lines. In patient samples, LINC01515 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
